275 related articles for article (PubMed ID: 14736836)
21. Clinical value of manual fusion of PET and CT images in patients with suspected recurrent colorectal cancer.
Nakamoto Y; Sakamoto S; Okada T; Senda M; Higashi T; Saga T; Togashi K
AJR Am J Roentgenol; 2007 Jan; 188(1):257-67. PubMed ID: 17179375
[TBL] [Abstract][Full Text] [Related]
22. Clinical role of 18F-FDG PET/CT in the management of squamous cell carcinoma of the head and neck and thyroid carcinoma.
Quon A; Fischbein NJ; McDougall IR; Le QT; Loo BW; Pinto H; Kaplan MJ
J Nucl Med; 2007 Jan; 48 Suppl 1():58S-67S. PubMed ID: 17204721
[TBL] [Abstract][Full Text] [Related]
23. PET/CT in diagnostic oncology.
Messa C; Bettinardi V; Picchio M; Pelosi E; Landoni C; Gianolli L; Gilardi MC; Fazio F
Q J Nucl Med Mol Imaging; 2004 Jun; 48(2):66-75. PubMed ID: 15243404
[TBL] [Abstract][Full Text] [Related]
24. Detection of histologically proven peritoneal carcinomatosis with fused 18F-FDG-PET/MDCT.
Dirisamer A; Schima W; Heinisch M; Weber M; Lehner HP; Haller J; Langsteger W
Eur J Radiol; 2009 Mar; 69(3):536-41. PubMed ID: 18248928
[TBL] [Abstract][Full Text] [Related]
25. FDG PET with contrast-enhanced CT: a critical imaging tool for laryngeal carcinoma.
Chu MM; Kositwattanarerk A; Lee DJ; Makkar JS; Genden EM; Kao J; Packer SH; Som PM; Kostakoglu L
Radiographics; 2010 Sep; 30(5):1353-72. PubMed ID: 20833855
[TBL] [Abstract][Full Text] [Related]
26. Diagnostic accuracy of 18F-FDG PET/CT in characterizing ovarian lesions and staging ovarian cancer: correlation with transvaginal ultrasonography, computed tomography, and histology.
Castellucci P; Perrone AM; Picchio M; Ghi T; Farsad M; Nanni C; Messa C; Meriggiola MC; Pelusi G; Al-Nahhas A; Rubello D; Fazio F; Fanti S
Nucl Med Commun; 2007 Aug; 28(8):589-95. PubMed ID: 17625380
[TBL] [Abstract][Full Text] [Related]
27. Contrast-enhanced PET/MR imaging versus contrast-enhanced PET/CT in head and neck cancer: how much MR information is needed?
Kuhn FP; Hüllner M; Mader CE; Kastrinidis N; Huber GF; von Schulthess GK; Kollias S; Veit-Haibach P
J Nucl Med; 2014 Apr; 55(4):551-8. PubMed ID: 24491410
[TBL] [Abstract][Full Text] [Related]
28. Clinical performance of PET/CT in evaluation of cancer: additional value for diagnostic imaging and patient management.
Bar-Shalom R; Yefremov N; Guralnik L; Gaitini D; Frenkel A; Kuten A; Altman H; Keidar Z; Israel O
J Nucl Med; 2003 Aug; 44(8):1200-9. PubMed ID: 12902408
[TBL] [Abstract][Full Text] [Related]
29. Retrospective digital image fusion of multidetector CT and 18F-FDG PET: clinical value in pancreatic lesions--a prospective study with 104 patients.
Lemke AJ; Niehues SM; Hosten N; Amthauer H; Boehmig M; Stroszczynski C; Rohlfing T; Rosewicz S; Felix R
J Nucl Med; 2004 Aug; 45(8):1279-86. PubMed ID: 15299049
[TBL] [Abstract][Full Text] [Related]
30. Tumors in the tracheobronchial tree: CT and FDG PET features.
Park CM; Goo JM; Lee HJ; Kim MA; Lee CH; Kang MJ
Radiographics; 2009; 29(1):55-71. PubMed ID: 19168836
[TBL] [Abstract][Full Text] [Related]
31. Applications of positron emission tomography/computed tomography image fusion in clinical positron emission tomography-clinical use, interpretation methods, diagnostic improvements.
Cohade C; Wahl RL
Semin Nucl Med; 2003 Jul; 33(3):228-37. PubMed ID: 12931324
[TBL] [Abstract][Full Text] [Related]
32. Improved detection and characterization of adrenal disease with PET-CT.
Elaini AB; Shetty SK; Chapman VM; Sahani DV; Boland GW; Sweeney AT; Maher MM; Slattery JT; Mueller PR; Blake MA
Radiographics; 2007; 27(3):755-67. PubMed ID: 17495290
[TBL] [Abstract][Full Text] [Related]
33. PET-CT in oncology: making the most of CT.
Miles KA
Cancer Imaging; 2008 Oct; 8 Spec No A(Spec Iss A):S87-93. PubMed ID: 18852084
[TBL] [Abstract][Full Text] [Related]
34. PET and PET-CT for evaluation of colorectal carcinoma.
Delbeke D; Martin WH
Semin Nucl Med; 2004 Jul; 34(3):209-23. PubMed ID: 15202102
[TBL] [Abstract][Full Text] [Related]
35. The impact of image fusion in resolving discrepant findings between FDG-PET and MRI/CT in patients with gynaecological cancers.
Tsai CC; Tsai CS; Ng KK; Lai CH; Hsueh S; Kao PF; Chang TC; Hong JH; Yen TC
Eur J Nucl Med Mol Imaging; 2003 Dec; 30(12):1674-83. PubMed ID: 12937950
[TBL] [Abstract][Full Text] [Related]
36. Dual-modality PET/CT scanning with negative oral contrast agent to avoid artifacts: introduction and evaluation.
Antoch G; Kuehl H; Kanja J; Lauenstein TC; Schneemann H; Hauth E; Jentzen W; Beyer T; Goehde SC; Debatin JF
Radiology; 2004 Mar; 230(3):879-85. PubMed ID: 14764889
[TBL] [Abstract][Full Text] [Related]
37. Why most PET of lung and head-and-neck cancer will be PET/CT.
Goerres GW; von Schulthess GK; Steinert HC
J Nucl Med; 2004 Jan; 45 Suppl 1():66S-71S. PubMed ID: 14736837
[TBL] [Abstract][Full Text] [Related]
38. Integration of FDG-PET/CT into external beam radiation therapy planning: technical aspects and recommendations on methodological approaches.
Thorwarth D; Beyer T; Boellaard R; de Ruysscher D; Grgic A; Lee JA; Pietrzyk U; Sattler B; Schaefer A; van Elmpt W; Vogel W; Oyen WJ; Nestle U
Nuklearmedizin; 2012; 51(4):140-53. PubMed ID: 22473130
[TBL] [Abstract][Full Text] [Related]
39. PET/CT in oncology: integration into clinical management of lymphoma, melanoma, and gastrointestinal malignancies.
Schöder H; Larson SM; Yeung HW
J Nucl Med; 2004 Jan; 45 Suppl 1():72S-81S. PubMed ID: 14736838
[TBL] [Abstract][Full Text] [Related]
40. Automated 3-dimensional registration of stand-alone (18)F-FDG whole-body PET with CT.
Slomka PJ; Dey D; Przetak C; Aladl UE; Baum RP
J Nucl Med; 2003 Jul; 44(7):1156-67. PubMed ID: 12843232
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
